Table 2.
PTMs identified exclusively in the NP cohort.
|
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Frequency of modification per 1,000 potential modification sites | ||||||||||
|
| ||||||||||
| # NP | NP1 | NP2 | NP3 | NP4 | NP5 | NP6 | NP7 | NP8 | NP9 | |
| Allysine(K) | 1 | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cation:K(C-term) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 |
| Cation:Na(C-term) | 2 | 0.00 | 0.06 | 0.00 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| GlyGly(T) | 2 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.08 | 0.00 | 0.00 |
| Hex(N) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 |
| Hydroxyallysine(K) | 1 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Methyl(T) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 |
| Methylpyrroline(K) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 |
| Quinone(W) | 1 | 0.00 | 0.16 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quinone(Y) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 |
| Oxoalanine(S) | 1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 |
NP, no pancreatitis (controls); #NP, number of NP samples in which a specific PTM has been identified.